Literature DB >> 21226616

Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes.

Giovanni Musso1, Roberto Gambino, Maurizio Cassader.   

Abstract

Novel, culture-independent, molecular and metagenomic techniques have provided new insight into the complex interactions between the mammalian host and gut microbial species. It is increasingly evident that gut microbes may shape the host metabolic and immune network activity and ultimately influence the development of obesity and diabetes. We discuss the evidence connecting gut microflora to obesity and to type 1 and type 2 diabetes, and we present recent insights into potential mechanisms underlying this relationship: increased nutrient absorption from the diet, prolonged intestinal transit time, altered bile acid entero-hepatic cycle, increased cellular uptake of circulating triglycerides, enhanced de novo lipogenesis, reduced free fatty acid oxidation, altered tissue composition of biologically active polyunsaturated fatty acid, chronic low-grade inflammation triggered by the endotoxin toll-like receptor 4 axis, and altered intestinal barrier function.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21226616     DOI: 10.1146/annurev-med-012510-175505

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  209 in total

1.  Enteropathogenic Escherichia coli inhibits ileal sodium-dependent bile acid transporter ASBT.

Authors:  Fadi Annaba; Zaheer Sarwar; Ravinder K Gill; Amit Ghosh; Seema Saksena; Alip Borthakur; Gail A Hecht; Pradeep K Dudeja; Waddah A Alrefai
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-08       Impact factor: 4.052

Review 2.  Gut microbiome in health and disease: Linking the microbiome-gut-brain axis and environmental factors in the pathogenesis of systemic and neurodegenerative diseases.

Authors:  Shivani Ghaisas; Joshua Maher; Anumantha Kanthasamy
Journal:  Pharmacol Ther       Date:  2015-11-26       Impact factor: 12.310

Review 3.  Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.

Authors:  G Musso; M Cassader; F Rosina; R Gambino
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

Review 4.  The Role of the Gut Microbiome in Predicting Response to Diet and the Development of Precision Nutrition Models-Part I: Overview of Current Methods.

Authors:  Riley L Hughes; Maria L Marco; James P Hughes; Nancy L Keim; Mary E Kable
Journal:  Adv Nutr       Date:  2019-11-01       Impact factor: 8.701

Review 5.  Altered Gut Microbiota in Type 2 Diabetes: Just a Coincidence?

Authors:  Antonio Sircana; Luciana Framarin; Nicola Leone; Mara Berrutti; Francesca Castellino; Renato Parente; Franco De Michieli; Elena Paschetta; Giovanni Musso
Journal:  Curr Diab Rep       Date:  2018-09-13       Impact factor: 4.810

Review 6.  Role of Angptl4 in vascular permeability and inflammation.

Authors:  Liang Guo; Shao-Ying Li; Fu-Yun Ji; Yun-Feng Zhao; Yu Zhong; Xue-Jun Lv; Xue-Ling Wu; Gui-Sheng Qian
Journal:  Inflamm Res       Date:  2013-10-31       Impact factor: 4.575

Review 7.  Impact of gut microbiota on gut-distal autoimmunity: a focus on T cells.

Authors:  Maran L Sprouse; Nicholas A Bates; Krysta M Felix; Hsin-Jung Joyce Wu
Journal:  Immunology       Date:  2019-01-21       Impact factor: 7.397

8.  Commensal Neisseria Kill Neisseria gonorrhoeae through a DNA-Dependent Mechanism.

Authors:  Won Jong Kim; Dustin Higashi; Maira Goytia; Maria A Rendón; Michelle Pilligua-Lucas; Matthew Bronnimann; Jeanine A McLean; Joseph Duncan; David Trees; Ann E Jerse; Magdalene So
Journal:  Cell Host Microbe       Date:  2019-08-01       Impact factor: 21.023

Review 9.  Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases.

Authors:  Jinsha Liu; Joey Paolo Ting; Shams Al-Azzam; Yun Ding; Sepideh Afshar
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

Review 10.  Choline metabolites: gene by diet interactions.

Authors:  Tangi Smallwood; Hooman Allayee; Brian J Bennett
Journal:  Curr Opin Lipidol       Date:  2016-02       Impact factor: 4.776

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.